Below is a collection of research publications authored by our hematology faculty members, where they have contributed as either the first author or last author. In academic research, the first author typically plays a key role in conducting the study and writing the manuscript, while the last author often serves as the senior researcher or principal investigator overseeing the project.
2025
Last updated: 2025-12-01
| Authors | Publication | Journal |
|---|---|---|
| Rizzolo, A.; Miron, M.-C.; Delisle, J.-F.; Alos, N.; Campeau, P.M.; Mercier, F.; Meilleur, C.; Le François, V.; Bed́ard, P.; Ospina, L.; Bérubé, D.; Lortie, A.; Assouline, S. | Real-world experience of switching to taliglucerase among patients with Gaucher disease in Québec: A case series | Molecular Genetics and Metabolism Reports |
| Busque, L.; Beaudet, M.-É.; Harnois, M.; Moussa, H.; Szuber, N.; Mollica, L.; Delage, R.; Olney, H.; Laneuville, P.; Cournoyer, G.; Chamakhi, I.; Lalancette, M.; Talbot, D.; Éthier, V.; Desjardins, P.; Assouline, S. | Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study | Blood Cancer Journal |
| Ramgopal, M.N.; Lalezari, J.P.; Pires Dos Santos, A.G.; Krishnan, P.; Vaidya, T.R.; Zhou, F.; Betman, H.; Dorr, P.; Mostafa, N.M.; Alcaide, M.L.; Felizarta, F.; Routy, J.-P. | Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study | Nature Medicine |
| Assouline, S.; Mehta, A.; Hanel, W.; Doucet, S.; Johnston, P.B.; Danilov, A.; Cooper, B.W.; Chudnovsky, A.; Ding, J.; Long, T.; Stroopinsky, D.; Berg, D.; Alinari, L. | Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma | Clinical Lymphoma, Myeloma and Leukemia |
| Mercier, F.; Gife, V.; Aloyz, R.; Hulea, L. | Translational control of leukemic metabolism and disease progression | Trends in Cell Biology |
| Righetti, R.; Cinque, F.; Lebouché, B.; Ramos Ballesteros, L.; Routy, J.-P.; Klein, M.B.; Szabo, J.; Cox, J.; Falutz, J.; Haraoui, L.-P.; Costiniuk, C.T.; De Pokomandy, A.; Pembroke, T.; Constante, M.; Santos, M.; Sebastiani, G. | Distinct Gut Microbiota Signatures Are Associated with Severity of Metabolic Dysfunction-Associated Steatotic Liver Disease in People with HIV | International Journal of Molecular Sciences |
| Rizzolo, A.; Ben-Ezra, N.; Liu, R.; Salaciak, M.; Maliha, P.G.; Webster-Clarke, M.; Probst, S.; Johnson, N.A. | SUVR (SUVmax Lymphoma/SUVmax Liver) vs. Deauville score for predicting PFS in Hodgkin Lymphoma | Clinical and Translational Imaging |
| Gife, V.; Sharif-Askari, B.; Sadr Hashemi Nejad, A.; Aloyz, R.; Hulea, L.; Mercier, F. | Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants | Journal of Visualized Experiments |
| Margolese, S.; Reinhard, R.; Masching, R.; Mohammadzadeh, N.; Ancuta, P.; Angel, J.B.; Routy, J.-P.; Walmsley, S.; Chomont, N.; Costiniuk, C.T. | Reflections upon a life well-lived: A tribute to Ron Rosenes | Journal of Virus Eradication |
| Luo, O.D.; Rizzolo, A.; Pelletier, P.; Popradi, G. | Case Report of an ABO-Matched Post-Hematopoietic Stem Cell Transplant-Associated Autoimmune Hemolytic Anemia: A Diagnostic and Therapeutic Challenge | Transplantation Proceedings |
| Brailovski, E.; Harnois, M.; Busque, L.; Chamakhi, I.; Tremblay, A.; Desjardins, P.; Assouline, S. | Fibrosis and treatment-free remission in chronic myeloid leukaemia | British Journal of Haematology |
| Skeith, L.; Malinowski, A.K.; El-Chaâr, D.; Chan, W.-S.; Donnelly, J.; Chauleur, C.; Ganzevoort, W.; Wood, S.; Dubois, S.; McCarthy, C.; Buchmul̈ler, A.; Wiegers, H.; Gibson, P.S.; Ní Áinle, F.; Middeldorp, S.; Duffett, L.; Bates, S.M.; Garven, A.; Baxter, J.; Lethebe, B.C.; Rodger, M.A. | Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial | The Lancet Haematology |
| Uminski, K.; Perelman, I.; Tinmouth, A.; Mack, J. | Use of automated isovolemic hemodilution red-cell exchange in patients with sickle cell disease: A Canadian single center experience | Transfusion |
| Bienz, M.; Constanzo-Yanez, J.; Baillargeon, N.; Leiva-Torres, G.A.; Boileau, M.; Cloutier, M.; Laforce-Lavoie, A.; Robitaille, N. | Planning antepartum directed donations in preparation for neonatal cardiac surgery in the absence of compatible donors | Transfusion |
| Giorgini, G.; Silvestri, C.; Mboumba-Bouassa, R.-S.; Muller, C.; Frias-Boligan, K.; Kalkan, H.; Routy, J.-P.; Flamand, N.; Di Marzo, V.; Jenabian, M.-A.; Costiniuk, C.T. | Impact of Oral Cannabinoids on the Endocannabinoidome and Gut Microbiome in People with HIV on Antiretroviral Therapy (CTN PT028 Pilot Clinical Trial) | Cannabis and Cannabinoid Research |
| Matarasso Greenfeld, S.; Dmitrienko, S.; Shrier, I.; Deschênes, J.L.; Assouline, S. | Understanding the clinical approach to “pathologically ambiguous follicular lymphoma” through a Real-World cohort | Leukemia and Lymphoma |
| Nguyen, N.; Leclair, V.; Kaedbey, R.; Hudson, M. | Failure of daratumumab in the treatment of anti-synthetase syndrome: A case report | SAGE Open Medical Case Reports |
| Vulesevic, B.; Lu, J.; Lauscher, D.; Shelton, B.; Dubé, K.; Routy, J.-P.; Berini, C.; Costiniuk, C.T. | Awareness and willingness regarding organ donation among people with HIV in Canada | AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV |
2024
| Authors | Publication | Journal |
|---|---|---|
| Bu S.; Royston L.; Mabanga T.; Berini C.A.; Tremblay C.; Lebouché B.; Cox J.; Costiniuk C.T.; Durand M.; Isnard S.; Routy J.-P. | Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity | Frontiers in Immunology |
| Korsos V.; Ali A.; Malagon T.; Khosrow-Khavar F.; Thomas D.; Sirhan S.; Davison K.; Assouline S.; Cassis C. | End of life in haematology: quality of life predictors - retrospective cohort study | BMJ Supportive and Palliative Care |
| Isnard S.; Mabanga T.; Royston L.; Berini C.A.; Bu S.; Aiyana O.; Feng H.; Lebouché B.; Costiniuk C.T.; Cox J.; Kroemer G.; Durand M.; Routy J.-P. | Extracellular acyl-CoA-binding protein as an independent biomarker of COVID-19 disease severity | Frontiers in Immunology |
| Alayoubi A.M.; Khawaji Z.Y.; Mohammed M.A.; Mercier F.E. | CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia | Annals of Hematology |
| Lachaine J.; Beauchemin C.; Dodat F.; Au Y.; Evans W.K.; Leber B.; Paulson K.; Schuh A.; Storring J. | Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada | Acta Haematologica |
| Knecht H.; Johnson N.; Bienz M.N.; Brousset P.; Memeo L.; Shifrin Y.; Alikhah A.; Louis S.F.; Mai S. | Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to First-Line ABVD Therapy | Cancers |
| Bitektine E.; Hagh-Daoust H.; Michel R.P.; Isnard S.; Routy J.-P. | THE VALUE OF A PET SCAN IN SELECTING THE BEST LYMPH NODE TO BIOPSY, AND CONFIRMING THE DIAGNOSIS OF IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE WITH HLH AND EBV VIREMIA IN A PREVIOUSLY HEALTHY ADULT | European Journal of Case Reports in Internal Medicine |
| Bienz M.; Renaud C.; Liu J.R.; Wong P.; Pelletier P. | Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening? | Transfusion Medicine Reviews |
| Angelillo C.; Tock W.L.; Salaciak M.; Reid R.E.R.; Andersen R.E.; Maheu C.; Johnson N.A. | A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic | PLoS ONE |
| Elbaz C.; Hollestelle M.J.; Meijer P.; Liederman Z.; Selby R. | D-dimer—An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World | Seminars in Thrombosis and Hemostasis |
| Brenner B.G.; Ibanescu R.-I.; Oliveira M.; Margaillan G.; Lebouché B.; Thomas R.; Baril J.G.; Lorgeoux R.-P.; Roger M.; Routy J.-P. | Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022 | Viruses |
| Matasar M.; Bartlett N.L.; Shadman M.; Budde L.E.; Flinn I.; Gregory G.P.; Kim W.S.; Hess G.; El-Sharkawi D.; Diefenbach C.S.; Huang H.; To I.; Parreira J.; Wu M.; Kwan A.; Assouline S. | Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience From a Pivotal Phase I/II Trial | Clinical Lymphoma, Myeloma and Leukemia |
| Long C.; Al-Abdulmalek A.; Lai J.; Haegert D.G.; Isnard S.; Cournoyer D.; Routy J.-P. | HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS FOLLOWING THE ANTI-PD-1 NIVOLUMAB IN A PATIENT WITH GASTRIC CANCER AND ANKYLOSING SPONDYLITIS | European Journal of Case Reports in Internal Medicine |
| Royston L.; Jary A.; Berini C.A.; Mabanga T.; Lin J.; Pagliuzza A.; Chomont N.; Litvinov I.V.; Calmy A.; Leducq V.; Calvez V.; Marcelin A.-G.; Isnard S.; Routy J.-P. | Similar Viral and Immune Characteristics of Kaposi Sarcoma in ART-treated People Living With HIV and Older Patients With Classic Kaposi Sarcoma | Open Forum Infectious Diseases |
| Jankovic M.; Poon W.W.L.; Gonzales-Losada C.; Vazquez G.G.; Sharif-Askari B.; Ding Y.; Craplet-Desombre C.; Ilie A.; Shi J.; Wang Y.; Jayavelu A.K.; Orthwein A.; Mercier F.É. | The E3 ubiquitin ligase Herc1 modulates the response to nucleoside analogs in acute myeloid leukemia | Blood Advances |
| Mehraj V.; Chen J.; Routy J.-P. | Effects of statins beyond lipid-lowering agents in ART-treated HIV infection | Frontiers in Immunology |
| Assouline S. | Decitabine plus cedazuridine and venetoclax: the promise of an all-oral therapy for patients with myelodysplastic syndromes and chronic myelomonocytic leukaemia | The Lancet Haematology |
| Johnson N.; Morin R.D. | FL molecular subgroups come of age | Blood |